1 min to read News Posted on May 5, 2023 FDA Guidance Clarifies Approach to Decentralized Clinical Trials – Ropes & Gray LLP FDA Guidance Clarifies Approach to Decentralized Clinical Trials Source: FDA Guidance Clarifies Approach to Decentralized Clinical Trials – Ropes & Gray LLP share tweet share Tags: SPACs